ListarIkerketa-Artikuluak por tema "dementia"
Mostrando ítems 1-4 de 4
-
Budget impact analysis of the use of Souvenaid in patients with prodromal Alzheimer’s Disease in Spain
(Springer Nature, 2022)Introduction The effectiveness, safety, and cost-effectiveness of the use of Souvenaid for Alzheimer’s disease (AD) have been previously evidenced. To complete the economic analysis, there is a need to assess whether ... -
Dementia related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization
(Dove Medical Press Limitedprevalence, 2019)Background: Dementia-related neuropsychiatric symptoms (NPS) are the main determinant of family stress and institutionalization of patients. This study aimed to identify inequalities by gender and socioeconomic status ... -
Economic evaluation of supplementing the diet with 1 Souvenaid in patients with prodromal Alzheimer's disease
(BioMed Central Ltd. Part of Springer Nature, 2020)Background: The LipiDiDiet trial showed that Souvenaid, a medical food, might delay progression to dementia in prodromal Alzheimer’s disease (AD). The objective of this study was to assess the cost-utility of Souvenaid ... -
Validation of Random Forest Machine Learning Models to Predict Dementia-Related Neuropsychiatric Symptoms in Real-World Data
(IOS Press, 2020)Background: Neuropsychiatric symptoms (NPS) are the leading cause of the social burden of dementia but their role is underestimated. Objective: The objective of the study was to validate predictive models to separately ...